Postembolization Syndrome after Prostatic Artery Embolization: A Systematic Review
Research output: Contribution to journal › Review › Research › peer-review
Standard
Postembolization Syndrome after Prostatic Artery Embolization : A Systematic Review. / Svarc, Petra; Taudorf, Mikkel; Nielsen, Michael Bachmann; Stroomberg, Hein Vincent; Røder, Martin Andreas; Lönn, Lars.
In: Diagnostics, Vol. 10, No. 9, 659, 2020.Research output: Contribution to journal › Review › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Postembolization Syndrome after Prostatic Artery Embolization
T2 - A Systematic Review
AU - Svarc, Petra
AU - Taudorf, Mikkel
AU - Nielsen, Michael Bachmann
AU - Stroomberg, Hein Vincent
AU - Røder, Martin Andreas
AU - Lönn, Lars
PY - 2020
Y1 - 2020
N2 - Postembolization syndrome (PES) is the most common side effect of vascular embolization of solid organs. The aim of this review was to determine the incidence of PES and its individual components after prostatic artery embolization (PAE). A systematic review with a pre-specified search strategy for PubMed, Embase, Web of Science and Cochrane Library was performed according to PRISMA guidelines. Studies in English regarding PAE in humans with 10 or more participants were eligible for inclusion. No restrictions on participant demographics or PAE technique were imposed. The search returned 378 references, of which 32 studies with a total of 2116 patients met the inclusion criteria. The results for overall PES frequency and individual PES components were presented as median (interquartile range, (IQR)). Overall median PES frequency was 25.5% (12.5–45.8). The two most frequent individual PES components were dysuria/urethral burning and local pain, with a median frequency of 21.7% (13.8–33.3) and 20% (5.4–29.4), respectively. Most outcome measures were characterized by a marked lack of uniformity and inconsistency in reporting across studies. Development of a uniform reporting system would help the clinicians recognize and treat PES accordingly.
AB - Postembolization syndrome (PES) is the most common side effect of vascular embolization of solid organs. The aim of this review was to determine the incidence of PES and its individual components after prostatic artery embolization (PAE). A systematic review with a pre-specified search strategy for PubMed, Embase, Web of Science and Cochrane Library was performed according to PRISMA guidelines. Studies in English regarding PAE in humans with 10 or more participants were eligible for inclusion. No restrictions on participant demographics or PAE technique were imposed. The search returned 378 references, of which 32 studies with a total of 2116 patients met the inclusion criteria. The results for overall PES frequency and individual PES components were presented as median (interquartile range, (IQR)). Overall median PES frequency was 25.5% (12.5–45.8). The two most frequent individual PES components were dysuria/urethral burning and local pain, with a median frequency of 21.7% (13.8–33.3) and 20% (5.4–29.4), respectively. Most outcome measures were characterized by a marked lack of uniformity and inconsistency in reporting across studies. Development of a uniform reporting system would help the clinicians recognize and treat PES accordingly.
KW - Benign prostatic hyperplasia
KW - Postembolization syndrome
KW - Prostatic artery embolization
U2 - 10.3390/diagnostics10090659
DO - 10.3390/diagnostics10090659
M3 - Review
C2 - 32878325
AN - SCOPUS:85090752774
VL - 10
JO - Diagnostics
JF - Diagnostics
SN - 2075-4418
IS - 9
M1 - 659
ER -
ID: 249949887